58 российский вестник перинатологии и педиатрии, 4, 2008 П

  1. 

Марфана. Кардиология 2006; 1: 92—98.

  2. 

Нечаева Г.И., Викторова И.А. Синдом Марфана в 

практике кардиолога: диагностика, лечение, возмож-

ность беременности и родов. Кардиология 2005; 12: 

79—86.

third Millennium. Eur J Human Genet 2002; 10: 673—

681.

  4. 

gene mutation in neonatal Marfan syndrome. Arch Pediat 

Adolesc Med 2002; 156: 1081—1085.

  5. 

London: John Hopkins University Press 1988; 1676.

  6. 

Uyeda T., Takahashi T., Eto S. et al. Three novel mutations 

of the fibrillin-1 gene and ten single nucleotide polymor-

phisms of the fibrillin-3 gene in Marfan syndrome patients. 

J Hum Genet 2004; 49: 8: 404—407.

  7. 

Biggin A., Holman K., Bren M. et al. Detection of thirty 

novel FBN1 mutations in patients with Marfan syndrome 

of a related fibrillinopathy. Hum Mutat 2004; 23: 1—99.

  8. 

quences of cysteine mutations in calcium-binding epider-

mal growth factor modules of fibrillin-1. J Biol Chem 2004; 

279: 31: 32924—32931.

  9. 

Dietz H.C., Pyeritz R.E. Mutations in the human gene for 

fibrillin-1 (FBN1) in the Marfan syndrome and related dis-

orders. Hum Molec Genet 1995; 4: 1799—1809.

10. 

Marfan syndrome. MASS phenotype contratural arachno-

ductily and related conditions. In: Principles and practice 

of Medical Genetics, 3 rd ed Eds D.L. Rimoin, J.M. Con-

nor, R.E. Pyeritz. New York: Churchill Livinigstone 1996.

11. 

ed with manifestations of Marfan syndrome and congenital 

contractural arachnodactyly. J Med Genet 2004: 41: 5: 56.

12. 

in normal human FBN1 expression in a family with Mar-

fan syndrome: a potential modifier of phenotype? Hum 

Mol Genet 2003; 12: 18: 2269—2276.

13. 

Werneck C., Trask B., Broekelmann T. Identification of 

the a major microfibril-associated glycoprotein-1-binding 

domain in fibrillin-2. Biol Chem 2004; 279: 22: 23045—

23051.